Healthcare Realty Trust Statistics
Total Valuation
HR has a market cap or net worth of $6.42 billion. The enterprise value is $11.35 billion.
Important Dates
The next confirmed earnings date is Thursday, October 30, 2025, after market close.
| Earnings Date | Oct 30, 2025 |
| Ex-Dividend Date | Aug 14, 2025 |
Share Statistics
HR has 356.71 million shares outstanding. The number of shares has decreased by -6.65% in one year.
| Current Share Class | 351.61M |
| Shares Outstanding | 356.71M |
| Shares Change (YoY) | -6.65% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 0.96% |
| Owned by Institutions (%) | 105.41% |
| Float | 347.92M |
Valuation Ratios
| Price/FFO Ratio | 14.97 |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.17 |
| Forward PS | 5.28 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 13.66 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 9.28 |
| EV / EBITDA | 15.87 |
| EV / EBIT | 251.03 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.40, with a Debt / Equity ratio of 1.02.
| Current Ratio | 0.40 |
| Quick Ratio | 0.02 |
| Debt / Equity | 1.02 |
| Debt / EBITDA | 6.71 |
| Debt / FCF | n/a |
| Interest Coverage | 0.20 |
Financial Efficiency
Return on equity (ROE) is -7.52% and return on invested capital (ROIC) is 0.27%.
| Return on Equity (ROE) | -7.52% |
| Return on Assets (ROA) | 0.26% |
| Return on Invested Capital (ROIC) | 0.27% |
| Return on Capital Employed (ROCE) | 0.50% |
| Revenue Per Employee | $2.22M |
| Profits Per Employee | -$741,647 |
| Employee Count | 550 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1.30% in the last 52 weeks. The beta is 0.81, so HR's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | +1.30% |
| 50-Day Moving Average | 17.90 |
| 200-Day Moving Average | 16.44 |
| Relative Strength Index (RSI) | 45.25 |
| Average Volume (20 Days) | 3,456,131 |
Short Selling Information
The latest short interest is 18.35 million, so 5.15% of the outstanding shares have been sold short.
| Short Interest | 18.35M |
| Short Previous Month | 20.01M |
| Short % of Shares Out | 5.15% |
| Short % of Float | 5.28% |
| Short Ratio (days to cover) | 4.75 |
Income Statement
In the last 12 months, HR had revenue of $1.22 billion and -$407.91 million in losses. Loss per share was -$1.16.
| Revenue | 1.22B |
| Gross Profit | 758.83M |
| Operating Income | 45.21M |
| Pretax Income | -408.28M |
| Net Income | -407.91M |
| EBITDA | 715.16M |
| EBIT | 45.21M |
| Loss Per Share | -$1.16 |
Full Income StatementBalance Sheet
The company has $27.11 million in cash and $4.98 billion in debt, giving a net cash position of -$4.95 billion or -$13.89 per share.
| Cash & Cash Equivalents | 27.11M |
| Total Debt | 4.98B |
| Net Cash | -4.95B |
| Net Cash Per Share | -$13.89 |
| Equity (Book Value) | 4.88B |
| Book Value Per Share | 13.70 |
| Working Capital | -684.16M |
Full Balance SheetCash Flow
| Operating Cash Flow | 468.32M |
| Capital Expenditures | -285.99M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 62.08%, with operating and profit margins of 3.70% and -32.94%.
| Gross Margin | 62.08% |
| Operating Margin | 3.70% |
| Pretax Margin | -33.40% |
| Profit Margin | -32.94% |
| EBITDA Margin | 58.51% |
| EBIT Margin | 3.70% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.96, which amounts to a dividend yield of 5.33%.
| Dividend Per Share | $0.96 |
| Dividend Yield | 5.33% |
| Dividend Growth (YoY) | -5.65% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.65% |
| Shareholder Yield | 11.79% |
| Earnings Yield | -6.38% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for HR is $19.50, which is 8.39% higher than the current price. The consensus rating is "Buy".
| Price Target | $19.50 |
| Price Target Difference | 8.39% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | -1.29% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
